Chadwick Harman
Director de Operaciones en BLUE WATER VENTURES INTERNATIONAL, INC. .
Perfil
Chadwick S.
Harman currently works at Psycheceutical Bioscience, Inc., as Chief Operating Officer & Director from 2023 and Psycheceutical, Inc., as President from 2023.
Cargos activos de Chadwick Harman
| Empresas | Cargo | Inicio |
|---|---|---|
| BLUE WATER VENTURES INTERNATIONAL, INC. | Director de Operaciones | 12/12/2023 |
Psycheceutical, Inc.
 Psycheceutical, Inc. Pharmaceuticals: MajorHealth Technology Psycheceutical, Inc. is a private company that aims to bring safety and efficacy to psychedelic compounds. The company is based in Fort Lauderdale, FL. The company has a team with over 100 years of combined experience in development, regulatory approval processes, and commercialization across the pharmaceutical industry. The company has next-generation patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds and provide direct and profound benefits to those suffering from mental disorders. Psycheceutical is removing barriers to care by employing state-of-the-art patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds. Chad Harman has been the CEO of the company since 2021. | Presidente | 12/12/2023 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| BLUE WATER VENTURES INTERNATIONAL, INC. | Commercial Services |
| Empresas privadas | 1 |
|---|---|
Psycheceutical, Inc.
Psycheceutical, Inc. Pharmaceuticals: MajorHealth Technology Psycheceutical, Inc. is a private company that aims to bring safety and efficacy to psychedelic compounds. The company is based in Fort Lauderdale, FL. The company has a team with over 100 years of combined experience in development, regulatory approval processes, and commercialization across the pharmaceutical industry. The company has next-generation patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds and provide direct and profound benefits to those suffering from mental disorders. Psycheceutical is removing barriers to care by employing state-of-the-art patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds. Chad Harman has been the CEO of the company since 2021. | Health Technology |
- Bolsa de valores
- Insiders
- Chadwick Harman
